EN
HI
Summary
As of 14 Nov, 2026, Vivanza Biosciences stock price is ₹1.48. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Vivanza Biosciences has traded between ₹1.52 and ₹2.72.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹1.48.
Vivanza Biosciences has an upper circuit limit of ₹1.77 and a lower circuit limit of ₹1.19. The total value traded stands at ₹0.00, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Vivanza Biosciences also offers a dividend yield of 0%.
Vivanza Biosciences Share Price Chart
Vivanza Biosciences Share Key Metrics
Volume
0.00
Market Cap
7.00 CR
LTQ@LTP
0@1.48
ATP
0
Var Margin
26.15 %
Circuit Range
1.19-1.77
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1
Vivanza Biosciences Fundamentals
P/E Ratio
219.26
P/B Ratio
1.28
Div. Yield
0
Sector P/E
47.36
Sector P/B
1.71
Sec. Div. Yield
73.7
Vivanza Biosciences Resistance and Support
Pivot 1.48
Resistance
First Resistance
1.51
Second Resistance
1.53
Third Resistance
1.56
Support
First Support
1.46
Second Support
1.43
Third Support
1.41
Vivanza Biosciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 1.5 | 1.42 | -4.05% | 1.5 | 1.4 |
| Thu Nov 12 2026 | 1.45 | 1.48 | 0.68% | 1.5 | 1.45 |
| Wed Nov 11 2026 | 1.4 | 1.47 | 1.38% | 1.48 | 1.4 |
Vivanza Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-06 | Quarterly Results |
| 2026-11-03 | Quarterly Results |
| 2026-08-17 | Others |
| 2026-08-07 | Quarterly Results |
| 2026-08-01 | Quarterly Results |
| 2026-06-18 | Others |
| 2026-05-07 | Audited Results |
| 2026-05-04 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-09-01 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-12 | Audited Results |
| 2025-01-31 | Quarterly Results & Others |
| 2024-10-17 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Vivanza Biosciences News
Vivanza Biosciences Ltd - 530057 - Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited Held On 06.11.2026
Vivanza Biosciences reported its Q2 FY27 financial results with cons. revenue plunging 79.4% YoY to ₹11.41 crores. Net profit saw a significant decline of 75.8% YoY, landing at ₹0.14 crores for the quarter. Total expenses dropped to ₹11.22 crores from ₹54.80 crores YoY.
Nov 06 2026 19:43:11
Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for Postponement And Rescheduling Of Board Meeting Pursuant To Regulation 29 & 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Vivanza Biosciences has rescheduled its board meeting from November 03 to November 06, 2026. The board will meet to consider and approve the financial results for the quarter and half-year ended September 30, 2026.
Nov 03 2026 18:09:09
Read More
Vivanza Biosciences Management
| Name | Position |
|---|---|
| JA Mehta | Managing Director |
| Rina Kumari | Non Executive Independent Director |
Vivanza Biosciences Similar Stocks
Worldwide Aluminium Ltd.
18.79
0.00 (0.00%)
Gratex Industries Ltd.
16.63
0.00 (0.00%)
Nyssa Corporation Ltd.
1.97
0.00 (0.00%)
Sunraj Diamond Exports Ltd.
11.31
0.00 (0.00%)
Artemis ADR Marketplace Ltd.
0.00
0.00 (0.00%)
Brawn Biotech Ltd.
22.00
0.00 (0.00%)
Lexoraa Industries Ltd.
14.80
0.00 (0.00%)
Amanaya Ventures Ltd.
18.90
0.00 (0.00%)
Munoth Communication Ltd.
5.96
0.00 (0.00%)
Vivanza Biosciences FAQs
The Buying Price of Vivanza Biosciences share is 1.48 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Vivanza Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vivanza Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Vivanza Biosciences shares is 219.26. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Vivanza Biosciences shares is 1.28. Useful to assess the stock's value relative to its book value.
To assess Vivanza Biosciences’s valuation compare Sector P/E, P/B which are 47.36 & 1.71 with sector averages, along with growth rates and financial metrics.
The Market Cap of Vivanza Biosciences is 7.00 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Vivanza Biosciences share price is 2.72 & 1.52. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Vivanza Biosciences belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in VIVANZA
